NASDAQ:MDVL

MedAvail (MDVL) Stock Forecast, Price & News

$0.24

+0.01 (+4.33%)

(As of 05/31/2023 ET)

Compare

Today's Range: $0.23
▼
$0.25
50-Day Range: $0.17
▼
$0.33
52-Week Range: $0.10
▼
$1.82

Volume: 73,333 shs
Average Volume: 82,534 shs
Market Capitalization: $19.41 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.00

MedAvail MarketRank™ Forecast

Analyst Rating: N/A
0.00 Rating Score
Upside/Downside: 1,144.3% Upside
$3.00 Price Target
Short Interest: Healthy
0.35% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
$32,725 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($0.30) to ($0.13) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.57 out of 5 stars

Medical Sector

823rd out of 1,006 stocks

Drug Stores & Proprietary Stores Industry

4th out of 6 stocks

2.0

Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of $3.00, MedAvail has a forecasted upside of 1,144.3% from its current price of $0.24.
Amount of Analyst Coverage
MedAvail has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.35% of the outstanding shares of MedAvail have been sold short.
Short Interest Ratio / Days to Cover
MedAvail has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in MedAvail has recently increased by 31.04%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
MedAvail does not currently pay a dividend.
Dividend Growth
MedAvail does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MDVL.

1.4

News and Social Media Coverage

News Sentiment
MedAvail has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for MedAvail this week, compared to 1 article on an average week.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, MedAvail insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $32,725.00 in company stock.
Percentage Held by Insiders
Only 3.70% of the stock of MedAvail is held by insiders.
Percentage Held by Institutions
86.77% of the stock of MedAvail is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for MedAvail are expected to grow in the coming year, from ($0.30) to ($0.13) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of MedAvail is -0.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of MedAvail is -0.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
MedAvail has a P/B Ratio of 4.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About MedAvail (NASDAQ:MDVL) Stock

MedAvail Holdings, Inc. is a pharmacy technology and services company, which engages in the development and commercialization of a self-service pharmacy, mobile application, and kiosk. It operates through the Retail Pharmacy Services and Pharmacy Technology segments. The Retail Pharmacy Services segment includes MedAvail Pharmacy Inc. and does business under the trade name SpotRx Pharmacy. The Pharmacy Technology segment represents MedAvail Technologies Inc. that sells the system including MedCenter prescription dispensing kiosk, software, integration, and maintenance services. The company was founded on April 11, 2007 and is headquartered in Phoenix, AZ.

Receive MDVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter.

MDVL Stock News Headlines

May 19, 2023 | finanznachrichten.de

MedAvail Holdings, Inc.: MedAvail Reports First Quarter 2023 Financial Results

May 18, 2023 | msn.com

MedAvail Holdings GAAP EPS of -$0.16, revenue of $0.62M

June 1, 2023 | Vantage Point (Ad)

Instantly Find Hidden Trade Opportunities

There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market.

May 18, 2023 | msn.com

MedAvail Holdings: Q1 Earnings Insights

May 18, 2023 | finance.yahoo.com

MedAvail Reports First Quarter 2023 Financial Results

May 18, 2023 | finance.yahoo.com

MedAvail to Report First Quarter 2023 Financial Results on May 18

May 15, 2023 | finance.yahoo.com

MedAvail to Report First Quarter 2023 Financial Results on May 15

May 15, 2023 | finance.yahoo.com

MedAvail Postpones Reporting of First Quarter 2023 Financial Results

June 1, 2023 | Vantage Point (Ad)

Instantly Find Hidden Trade Opportunities

May 10, 2023 | marketwatch.com

8-K: MedAvail Holdings, Inc.

April 15, 2023 | finanznachrichten.de

MedAvail Holdings, Inc.: MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results

April 13, 2023 | finance.yahoo.com

MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results

April 12, 2023 | finance.yahoo.com

MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13

March 30, 2023 | finance.yahoo.com

MedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial Results

March 29, 2023 | benzinga.com

MedAvail Holdings's Earnings: A Preview

March 29, 2023 | markets.businessinsider.com

What Wall Street expects from MedAvail's earnings

March 29, 2023 | americanbankingnews.com

MedAvail (MDVL) Scheduled to Post Earnings on Thursday

March 16, 2023 | finance.yahoo.com

MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30

March 14, 2023 | finance.yahoo.com

MedAvail Announces Closing of $16 Million Private Placement

January 26, 2023 | finance.yahoo.com

MedAvail announces Sale of Pharmacy Assets to CVS Pharmacy

January 19, 2023 | finance.yahoo.com

MedAvail announces Strategic Restructuring of Business to Focus on Profitability

November 17, 2022 | finance.yahoo.com

MedAvail Ranked in the Top 500 Fastest-Growing Companies in North America

November 10, 2022 | finance.yahoo.com

MedAvail Reports Third Quarter 2022 Financial Results

October 27, 2022 | finance.yahoo.com

MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022

October 26, 2022 | finance.yahoo.com

MedAvail Announces Technology Partnership with Progressive Care, Inc

October 19, 2022 | globenewswire.com

Pharmacy Automation Market Growing at Remarkable Growth of 9.88 Billion by 2029, Key Drivers, Size, Share, Demand and Opportunity Analysis - GlobeNewswire

October 11, 2022 | seekingalpha.com

MDVL MedAvail Holdings, Inc.

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MDVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter.

MDVL Company Calendar

Last Earnings: 11/08/2021
Today: 5/31/2023
Next Earnings (Estimated): 8/10/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Drug stores & proprietary stores
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:MDVL
CUSIP: N/A
CIK: 1402479
Web: www.medavail.com
Phone: (905) 812-0023
Fax: 973-348-5707
Employees: 287
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $3.00
High Stock Price Forecast: $5.00
Low Stock Price Forecast: $1.00
Forecasted Upside/Downside: +1,144.3%
Consensus Rating: N/A
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.68)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-47,620,000.00
Net Margins: -150.00%
Pretax Margin: -157.41%
Return on Equity: -211.71%
Return on Assets: -109.96%

Debt

Debt-to-Equity Ratio: 0.34
Current Ratio: 6.34
Quick Ratio: 4.64

Sales & Book Value

Annual Sales: $43.11 million
Price / Sales: 0.45
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.05 per share
Price / Book: 4.82

Miscellaneous

Outstanding Shares: 80,520,000
Free Float: 79,155,000
Market Cap: $19.41 million
Optionable: Not Optionable
Beta: 0.38

Key Executives

Mark Doerr
President, Chief Executive Officer & Director

Ramona Seabaugh
Chief Financial Officer

David John Rawlins
Chief Commercial Officer

Bob McClune
Senior Vice President-Data & Analytics

Will Misloski
Chief Marketing Officer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

MDVL Stock - Frequently Asked Questions

What is MedAvail's stock price forecast for 2023?: 0 Wall Street research analysts have issued twelve-month target prices for MedAvail's stock. Their MDVL share price forecasts range from $1.00 to $5.00. On average, they anticipate the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 1,144.3% from the stock's current price.
View analysts price targets for MDVL or view top-rated stocks among Wall Street analysts.
How have MDVL shares performed in 2023?: MedAvail's stock was trading at $0.2998 at the start of the year. Since then, MDVL shares have decreased by 19.6% and is now trading at $0.2411.
View the best growth stocks for 2023 here.
Are investors shorting MedAvail?: MedAvail saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 283,300 shares, an increase of 31.0% from the April 30th total of 216,200 shares. Based on an average daily trading volume, of 111,500 shares, the short-interest ratio is presently 2.5 days.
View MedAvail's Short Interest.
When is MedAvail's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our MDVL earnings forecast.
How were MedAvail's earnings last quarter?: MedAvail Holdings, Inc. (NASDAQ:MDVL) posted its quarterly earnings results on Monday, November, 8th. The company reported ($0.34) earnings per share for the quarter, missing analysts' consensus estimates of ($0.32) by $0.02. The firm had revenue of $5.79 million for the quarter. MedAvail had a negative trailing twelve-month return on equity of 211.71% and a negative net margin of 150.00%. During the same quarter in the previous year, the company earned ($0.84) earnings per share.

What is MedAvail's stock symbol?: MedAvail trades on the NASDAQ under the ticker symbol "MDVL."
How do I buy shares of MedAvail?: Shares of MDVL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is MedAvail's stock price today?: One share of MDVL stock can currently be purchased for approximately $0.24.
How much money does MedAvail make?: MedAvail (NASDAQ:MDVL) has a market capitalization of $19.41 million and generates $43.11 million in revenue each year. The company earns $-47,620,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis.
How many employees does MedAvail have?: The company employs 287 workers across the globe.
How can I contact MedAvail?: MedAvail's mailing address is 45 HORSEHILL ROAD SUITE 106, CEDAR KNOLLS NJ, 07927. The official website for the company is www.medavail.com. The company can be reached via phone at (905) 812-0023, via email at jgoodford@myoscorp.com, or via fax at 973-348-5707.

This page (NASDAQ:MDVL) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial